The Company is a Korea-based company that researches and develops new drugs. The Company is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others. The Company was established on July 24, 2009. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on June 12, 2019.
Headquarters
Heungdeok It Valley, 13, Heungdeok 1-Ro, Giheung-Gu
Yongin; Gyeonggi;
Contact Details: Purchase the Aptabio Therapeutics Inc. report to view the information.
Website: http://www.aptabio.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service